Croda International (CRDA.L) Stock Analysis & Winston Score
Croda International is a British specialty chemicals company. It makes high-performance ingredients that other companies use inside their products — things like moisturizers in skincare creams, delivery systems in medicines, and additives in crop protection sprays. Its main customers are consumer goods brands, pharmaceutical companies, and agricultural businesses. Croda earns money by selling these specialty ingredients to manufacturers around the world. It operates globally, with a strong presence in Europe, North America, and Asia, and generates roughly $2 billion in annual revenue. Its competitive edge comes from deep formulation expertise and long-standing customer relationships — switching to a rival supplier is costly and slow for customers. The key growth driver is its life sciences division, particularly lipid systems used in drug delivery, including mRNA vaccines. The main risk is that demand in its consumer care segment has been soft as large consumer brands work through excess inventory, which has pressured margins and returns in recent years.
Winston Score: 43/100 — Average
Mixed quality — meaningful strengths and weaknesses.
- Quality: Mixed (13/30)
- Growth: Weak (3/20)
- Cash Flow: Strong (8/10)
- Stability: Strong (8/10)
- Valuation: Weak (1/10)
- Ownership: Good (8/15)
Key Facts
Price: 3,433.00 GBp
Market Cap: £4.8B
Sector: Basic Materials
Industry: Chemicals - Specialty
Exchange: London Stock Exchange



